Lens internal curvature effects on age-related eye model and lens paradox.

Biomed Opt Express

College of Science and Technology, School of Science & Technology, Nottingham Trent University, Nottingham, UK.

Published: November 2017

The gradient index (GRIN) model is the most accurate way to represent the eye lens which, because of its growth mode, is a lamellar, shell-like structure. The GRIN is thought to provide optical properties that counteract age-related changes in curvature that would otherwise create an increasingly myopic eye: the so-called lens paradox. This article investigates how fine-tuning the refractive index and the internal curvatures of the lenticular indicial contours may prevent the ageing eye from becoming myopic. A system matrix approach is applied for analysis of a shell model with 200 shells to obtain the paraxial characteristics of the eye model.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695934PMC
http://dx.doi.org/10.1364/BOE.8.004827DOI Listing

Publication Analysis

Top Keywords

eye model
8
lens paradox
8
eye
5
lens
4
lens internal
4
internal curvature
4
curvature effects
4
effects age-related
4
age-related eye
4
model
4

Similar Publications

Glaucoma, a leading cause of irreversible blindness, is characterized by the progressive loss of retinal ganglion cells (RGCs) and optic nerve damage, often associated with elevated intraocular pressure (IOP). Retinoid X receptors (RXRs) are ligand-activated transcription factors crucial for neuroprotection, as they regulate gene expression to promote neuronal survival via several biochemical networks and reduce neuroinflammation. This study investigated the therapeutic potential of 9-cis-13,14-dihydroretinoic acid (9CDHRA), an endogenous retinoid RXR agonist, in mitigating RGC degeneration in a high-IOP-induced experimental model of glaucoma.

View Article and Find Full Text PDF

Canonical and non-canonical Wnt signaling pathways are well-characterized regulators of retinal development. Wnt signaling also promotes neuroprotection and regeneration in adult tissues, including retinal ganglion cell (RGC) survival and axonal regrowth after optic nerve injury. However, it is unknown whether Wnt-dependent neuroprotection after injury in the adult CNS is associated with altered expression of developmental genes.

View Article and Find Full Text PDF

ObjectiveTo assess the cost-effectiveness of faricimab versus other anti-vascular endothelial growth factor (anti-VEGF) drugs for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) in Japan, while considering societal burden associated with treatment.MethodsA Markov model for cost-effectiveness analysis of anti-VEGF treatment in patients with nAMD and DME was applied based on cost and utility value data from Japan. Faricimab administered through a treat-and-extend (T&E) regimen was compared with ranibizumab administered pro re nata (PRN) and T&E, aflibercept T&E, brolucizumab T&E, and best supportive care (BSC).

View Article and Find Full Text PDF

BackgroundPrimary open-angle glaucoma (POAG) is a chronic, progressive and irreversible eye disease. Currently, there is no effective way to prevent optic nerve damage.ObjectiveThis study explored POAG gene markers to identify high-risk groups at an early stage and to find new effective therapeutic targets.

View Article and Find Full Text PDF

Rapid-eye-movement (REM) sleep behaviour disorder (RBD) is a primary sleep disorder strongly associated with Parkinson's disease. Assessing sleep structure in RBD is important for understanding the underlying pathophysiology and developing diagnostic methods. However, the performance of automated sleep stage classification (ASSC) models is considered suboptimal in RBD, for both models utilising neurological signals ("ExG": EEG, EOG, and chin EMG) and heart rate variability combined with body movements (HRVm).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!